Dr. Alfred Di Stefano, MD
What this data tells you about Dr. Di Stefano
Dr. Alfred Di Stefano is a hematology & oncology in Arlington, TX, with 20 years in practice. Based on federal Medicare data, Dr. Di Stefano performed 19,880 Medicare services across 1,290 unique beneficiaries.
Between the years covered by Open Payments, Dr. Di Stefano received a total of $1,886 from 31 pharmaceutical and/or device companies across 123 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Di Stefano is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia | 13,385 | $2 | $20 |
| Contrast dye for imaging (iodine-based) | 2,004 | $0 | $3 |
| Dexamethasone injection (steroid) | 1,087 | $0 | $1 |
| Blood draw (venipuncture) | 464 | $8 | $20 |
| Complete blood count (CBC) with differential | 434 | $8 | $36 |
| Comprehensive metabolic blood panel | 411 | $10 | $64 |
| Office visit, established patient (20-29 min) | 291 | $65 | $250 |
| Flow cytometry, additional marker | 272 | $18 | $180 |
| Administration of chemotherapy into vein, 1 hour or less | 208 | $101 | $707 |
| Office visit, established patient (30-39 min) | 158 | $93 | $368 |
| Injection of additional new drug or substance into vein | 132 | $12 | $108 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 116 | $23 | $157 |
| Drug injection, under skin or into muscle | 111 | $11 | $96 |
| Administration of chemotherapy into vein, each additional hour | 87 | $22 | $161 |
| Administration of additional new drug or substance into vein, 1 hour or less | 71 | $51 | $344 |
| Iron level test | 65 | $6 | $27 |
| Ferritin level test (iron stores) | 64 | $13 | $60 |
| Iron binding capacity test | 64 | $8 | $35 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 57 | $336 | $1,722 |
| Irrigation of implanted venous access drug delivery device | 53 | $19 | $114 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 51 | $49 | $313 |
| Injection, diphenhydramine hcl, up to 50 mg | 50 | $1 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 44 | $16 | $100 |
| Administration of additional new drug or substance into vein using push technique | 42 | $43 | $289 |
| Hospital follow-up visit, moderate complexity | 40 | $60 | $247 |
| Immunoglobulin level test | 39 | $9 | $56 |
| Reticulated (young) platelet measurement | 31 | $35 | $143 |
| Ct scan of chest with contrast | 22 | $55 | $821 |
| CT scan of abdomen and pelvis with contrast | 14 | $175 | $1,067 |
| Flow cytometry technique for dna or cell analysis, first marker | 13 | $41 | $298 |
Industry Payment Transparency
Open Payments through 2023 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2023)
Associated products mentioned in payments ›
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Di Stefano is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Di Stefano experienced with darbepoetin injection (aranesp) for anemia?
Does Dr. Di Stefano receive payments from pharmaceutical companies?
How do Dr. Di Stefano's costs compare to other hematology & oncologys in Arlington?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology